Sold by: Medisafe Inc.
Deployed on AWS
Gain actionable insights from self-identified reasons for non-adherence to a missed dose by patients self-report taking a combination of antidiabetic DPP-4 Inhibitors and/or additional medications . Assess and trend patient mindsets from the self-reported and de-identified Medisafe users indicating reasons for skipping specific doses from a complex medication regimen.
Overview
Medisafe has a comprehensive database of de-identified medication adherence activity and behaviors. This product represents one subset of this data. To learn more about our insights- - contact us at dataaws@medisafe.com )
This product provides a snapshot of US Medisafe users who report taking DPP-4 class drug in combination with additional (including supplements and over-the-counter) medications who also responded to a survey of reasons for skipping any dose of a scheduled medication. This self-reported de-identified data includes gender and age characteristics as well as responses to the Medisafe generated survey identifying the mindset of skipped dose behaviors . Gain actionable insights by tracking trends, commonalities and outliers from a targeted population of patients self-reporting and tracking their medications.
Highlights
- Drug Class: DPP-4 Inhibitors and Combinations
- Learn self-identified reasons for skipping medication doses
- View (de-identified) user segments by age and gender breakdown, adherence level, time on medication and self-reported reasons for skipping doses
- Initial file includes dataset from most recently ended quarter
- Subsequent dataset file for most recently ended quarter/month until end of subscription
- Geographic coverage: USA
General Description: Medisafe is the leader of digital therapeutic companions for medication management. Currently there are over six million users world-wide who have incorporated our holistic approach to medication management into their everyday lives. Medisafe has generated over 12 billion data points of de-identified data representing medication behaviors spanning diverse therapeutic areas. Medisafe’s data products are sourced from real-world behaviors while maintaining the highest degree of patient privacy and security protection. Our de-identified data sets combine age and gender demographics, self reported medication management and digital behavior patterns and is both HIPAA and GDPR compliant.
The data products offered on AWS are exclusively for qualified research endeavors. If interested in purchasing any of our data products we invite you to submit your request here dataaws@medisafe.com and we will reach out to discuss terms and prices.
Updated: December 5, 2019
Product subscription includes: initial snapshot file from most recent completed quarter of the year, and subsequent quarterly (or monthly) snapshots for duration of annual subscription. Product subscription renewed annually.
Details
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
Pricing is based on the duration and terms of your contract with the vendor. This entitles you to a specified quantity of use for the contract duration. If you choose not to renew or replace your contract before it ends, access to these entitlements will expire.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Dimension | Description | Cost/12 months |
|---|---|---|
Product Access | Dimension that grants access to the product for subscribers. | $36,000.00 |
Vendor refund policy
No refunds. Can’t find a solution for your use case? Contact us at dataaws@medisafe.com .
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
Non-adherence reasons : DPP-4 Inhibitors and Combinations | All historical revisions | All future revisions | Not included | Not included |
Similar products
Deep Learning model to predict the eligibility of a patient for a cancer clinical trial after going through patient's diagnosis notes.
Predicts hospital readmission rate of a patient using Random Forrest algorithm
Huron Rounding is a one-stop tool that helps your team improve patient satisfaction by aligning patient needs to care delivery. Enable leaders to make data-driven decisions that support patient safety and bolster the overall patient experience.
The Patient Lab Report Analyzer, powered by Claude 3.5, empowers users to upload their lab reports, extract detailed information, and ask NLP-driven questions for insightful analysis. This tool enhances the understanding of lab results, making it easier for patients and healthcare providers to interpret and utilize lab data effectively. Developed by GoML, a leader in Generative AI solutions, this product leverages state-of-the-art technology to provide a seamless and informative user experience.
The FDA Patient Focused Drug Development guidance is mandating our industry take a more patient centric approach, and listening is essential for designing truly patient centered studies. inVibe Patient Listening is technology-driven market research -- leveraging automated voice-response and artificial intelligence (AI) features -- to ensure study sponsors and CROs are listening to patients and caregivers throughout the drug development lifecycle. Simple, systematic, and scalable.